Melodiol Global Health
- Short interest
- 0.00%
- 0.00 pp 30d
- as of 28 June 2024
- Reported shorts
- 592
- Shares on issue
- 194.092M
Melodiol Global Health (ME1) Short Interest
Melodiol Global Health (ASX:ME1) had 0.00% of shares reported as short positions as of 28 June 2024, representing 592 shares. Melodiol Global Health operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4About Melodiol Global Health
Developing, registering and commercialising pharmaceutical-grade cannabis and hemp-based products for use across a broad spectrum of consumer,. Industry and research applications.
Company profile →Melodiol Global Health (ASX:ME1) has 0.00% of its shares on issue reported as short positions as of 28 June 2024, or about 592 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. Its highest recorded short interest was 0.19% in February 2024. ME1 is classified in the Pharmaceuticals, Biotechnology & Life Sciences industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Short interest
History & FAQ →Weekly context: The 10 most shorted ASX stocks — Week 41, 2026.
Latest ME1 news
All news- Removal from Official List
asx · 27 Oct 2024
- Notification of cessation of securities - ME1
asx · 22 Oct 2024
- Notification of cessation of securities - ME1
asx · 7 Oct 2024
Company details
website
address
More Pharmaceuticals, Biotechnology & Life Sciences Stocks
Other shorted stocks in this sector
Be the first to discuss ME1
Start a research thread or post the first pulse update